维普期刊资源整合服务平台（V6.5）

118篇 您的检索式：作者名="Walker SR"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Cardiovasculair risk factors after antenatal exposure to betamethasene:30-year follow-up of a randomised contmUed trial显示文摘	Walker NK Parag V	2005	Lancet2005，365，9474：	1
2	Long - term clinical efficacy of grass -pollen immunotherapy 显示文摘	Durham SR Walker SM Varga EM	2005	N Engl J MED2005，54，：	1
3	Hospitalized patients with2009H1N1influenza in the United States,April-June2009显示文摘	Jain S Kamimoto L Bramley AM Schmitz AM Benoit SR Louie J Sugerman DE Druckenmiller JK Ritger KA Chugh R Jasuja S Deutscher M Chen S Walker JD Duchin JS Lett S Soliva S Wells EV Swerdlow D Uyeki TM Fiore AE Olsen SJ Fry AM Bridges CB Finelli L 2009Pandemic Influenza A(H1N1)Virus Hospitalizations Investigation Team	2009	N Engl J Med2009，361，20：	1
4	Long-term clinical efficacy of grass-pollen immunotherapy 显示文摘	Durham SR Walker SM Varga EM	1999	N Engl J Med1999，341，7：	1
5	The need for a control animal pathology database: an interiational survey 显示文摘	Lumley CE Walker SR	1999	Toxicol Pathol1999，10，3：	1
6	The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors 显示文摘	Nelson EA Walker SR Weisberg'E	2011	Blood2011，117，12：	1
7	The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors显示文摘	Nelson EA Walker SR Weisberg E	2011	Blood2011，117，12：	1
8	Long- term clinical efficacy of grass2pollen immunotherapy显示文摘	Durham SR Walker SM Varga EM	1999	N Engl J Med1999，341，：	1
9	Pharmaceutical innovation by seven UK-owned pharmaceutical companies(1964-1985)显示文摘	Prentis RA Lis Y Walker SR	1998	Br J Clin Pharmacol1998，25，：	1
10	People living in ageing buildings : their quality of life and sense of belonging 显示文摘	Walker SR Rosser RW	2005	J Environm Pshcho12005，3，：	1
11	A 10-year follow-up of patients presenting with ischaemic rest pain of the lower limbs显示文摘	Walker SR Yusuf SW Hopkinson BR	1998	Eur J Vase Endovasc Surg1998，15，：	1
12	Reciprocal effects of Stat5 and Stat3 in breast cancer 显示文摘	Walker SR Nelson EA Zou L	2009	Mol Cancer Res2009，7，6：	1
13	Long-term clinical efficacy of grass-pollen immunotherapy显示文摘	Durham SR Walker SM Varga EM	1999	N Engl J Med1999，341，7：	1
14	Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985) 显示文摘	Prentis RA Lis Y Walker SR	1988	Br J Clin Pharmacol1988，25，：	1
15	The STAT5 inhibitor pimozide decreases survival of chronic myeloge- nous leukemia cells resistant to kinase inhibitors显示文摘	Nelson EA Walker SR Weisberg E	2011	Blood2011，117，12：	1
16	long-term clinical efficacy of grass -pollen immunotherapy显示文摘	Durham SR Walker SM Varga EM	1999	N Engl J Med1999，341，：	1
17	Subintimal angioplasty of native vessels in the management of occluded vascular grafts显示文摘	Walker SR Papavassiliou VG Bolia A	2001	Eur J Vasc Endovasc Surg2001，22，1：	1
18	Rab GAPs AS160 And tbc1d1 play nonredundant roles in the regulation of glucose and energy homeostasis in mice显示文摘	Hargett SR Walker NN Keller SR	2016	Am J Physiol Endocrinol Metab2016，310，4：	1
19	Identification of rat alveolar type Ⅱ epithelial cells with a tannic acid and polychrome stain显示文摘	Mason RJ Walker SR Shields BA	1985	Am Rev Respir Dis1985，131，5：	1
20	Trends in the development of new medicines by UK - owned pharmaceutical companies ( 1964 - 1980 ) 显示文摘	Prentis RA Walker SR	1986	Br J Clin Pharmacol1986，21，：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示